BUZZ-10x Genomics rises on collaboration to build patient tissue database

10x Genomics +1.27%

10x Genomics

TXG

22.33

+1.27%

** Shares of life sciences tech firm 10x Genomics TXG.O rise 3.58% to $20.52

** Privately-held biotech AI firm Bioptimus launches STELA, a global project to build a large database of patient tissue samples linked to clinical records, starting with cancer and immunology

** TXG will provide its Xenium platform to STELA for mapping gene activity in tissue samples, while another partner, Broad Clinical Labs, will help generate the data at scale under a multi-year agreement

** Bioptimus says the project will combine tissue images, spatial gene data, other molecular data and long-term patient records

** The companies did not disclose the financial terms of the deal

** TXG rose more than 13% in 2025


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.